BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26456520)

  • 1. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X; Guo J; Ding R; Lv B; Bi L
    Acta Histochem; 2015 Oct; 117(8):732-7. PubMed ID: 26456520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
    Sato S; Zhang XK; Matsuoka N; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Temmoku J; Fujita Y; Asano T; Migita K
    Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z; Liu D; Zhang X; Wang X
    Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
    Moreth K; Brodbeck R; Babelova A; Gretz N; Spieker T; Zeng-Brouwers J; Pfeilschifter J; Young MF; Schaefer RM; Schaefer L
    J Clin Invest; 2010 Dec; 120(12):4251-72. PubMed ID: 21084753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
    Ding ZX; Yang SF; Wu QF; Lu Y; Chen YY; Nie XL; Jie HY; Qi JM; Wang FS
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):656-60. PubMed ID: 21515463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q; Yang C; Wang Q; Zeng H; Qin W
    PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J; Sun M; Tian S
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B; Ye H; You X; Ni H; Chen X; Li L
    Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
    BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.